Blackwell Burke P.A. Wins Dismissal of Hebrew National Putative Nationwide Class Action
Blackwell Burke P.A. obtained a complete defense victory on behalf of firm client ConAgra Foods, Inc. in federal district court in Minnesota. The dismissal with prejudice comes in a putative nationwide class action where consumers alleged that ConAgra’s Hebrew National brand beef products were not “100% kosher” as advertised. In deciding that the plaintiffs’ claims […]
Blackwell Burke P.A. Partner Corey L. Gordon to Speak on Diacetyl at Grocery Manufacturers Association Conference
Blackwell Burke P.A. partner Corey L. Gordon will present at the Grocery Manufacturers Association (GMA) 2013 Litigation Conference. The GMA Conference is being held February 19-21, 2013 in Miami, Florida. Mr. Gordon’s presentation will take place on Wednesday, February 20. The GMA is the main trade group of the food industry. Its members include the […]
Peter J. Goss Discusses How Bankruptcy May Affect Consolidation of Meningitis Claims in Law 360
Law360 interviewed Blackwell Burke P.A. partner Peter J. Goss for an article about the U.S. Judicial Panel on Multidistrict Litigation’s (JDML) upcoming hearing on whether to centralize over 100 cases filed against the New England Compounding Center (NECC). These lawsuits arise from the NECC’s distribution of allegedly tainted steroids that resulted in meningitis. The decision whether […]
Blackwell Burke P.A. Wins Summary Judgment Victory for ExxonMobil
On January 22, 2013, a New Jersey federal district court granted summary judgment in favor of Blackwell Burke client ExxonMobil Oil Corporation. In JOC Inc. v. ExxonMobil Oil Corp., No. 2:08-cv-05344-SRC-CLW (D.N.J.), the plaintiff, a former franchisee, brought claims for price discrimination and breach of contract. The plaintiff claimed that ExxonMobil’s use of “zone pricing” constituted illegal […]
Law 360 Quotes Blackwell Burke P.A. Partner Peter J. Goss on Innovator Liability for Generic Drug Injuries
Law360 interviewed Blackwell Burke P.A. partner Peter J. Goss for an article about a recent Alabama Supreme Court ruling that branded pharmaceutical manufacturers could be liable for failure to warn in cases where the patient only took a generic version of the drug. This is the first decision to address the issue of “innovator liability” […]